HHS Engages Sanofi’s Recombinant Technology for COVID-19 Vaccine
HHS Engages Sanofi’s Recombinant Technology for COVID-19 Vaccine U.S. Department of Health and Human Services Washington, D.C. February 18, 2020 Racing to develop a vaccine against the 2019 COVID-19, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response has engaged Sanofi Pasteur, the vaccines global business unit ... Read More»